JAK Inhibitors for the Treatment of Pediatric Alopecia Areata-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

JAK Inhibitors for the Treatment of Pediatric Alopecia Areata

Published:2020-11 Issue:1 Volume:20 Page:S31-S36
ISSN:1087-0024
Container-title:Journal of Investigative Dermatology Symposium Proceedings
language:en
Short-container-title:Journal of Investigative Dermatology Symposium Proceedings

Author:

Hamilton Claire E.^ORCID,Craiglow Brittany G.^ORCID

Funder

National Alopecia Areata Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,General Medicine,Biotechnology

Reference57 articles.

1. A child with severe juvenile dermatomyositis treated with ruxolitinib;Aeschlimann;Brain,2018

2. Janus kinase inhibitors for the treatment of severe alopecia areata: an open-label comparative study;Almutairi;Dermatology,2019

3. Combined use of ruxolitinib and sirolimus: increased monitoring of triglycerides required;Bauters;Bone Marrow Transplant,2019

4. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata;Bayart;J Am Acad Dermatol,2017

5. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata;Bilgiç;J Eur Acad Dermatol Venereol,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata;Dermatologic Therapy;2024-01-05

2. Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients;Anais Brasileiros de Dermatologia;2023-11

3. Preparation and evaluation of dissolving tofacitinib microneedles for effective management of rheumatoid arthritis;European Journal of Pharmaceutical Sciences;2023-09

4. Quantitative analysis of JAK/STAT signaling pathway in patients of inflammatory skin disorders;Rheumatology International;2023-08-10

5. Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib;Journal of Cosmetic Dermatology;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3